...
首页> 外文期刊>Stem cells international >Primitive Sca-1 Positive Bone Marrow HSC in Mouse Model of Aplastic Anemia: A Comparative Study through Flowcytometric Analysis and Scanning Electron Microscopy
【24h】

Primitive Sca-1 Positive Bone Marrow HSC in Mouse Model of Aplastic Anemia: A Comparative Study through Flowcytometric Analysis and Scanning Electron Microscopy

机译:再生障碍性贫血小鼠模型中的原始Sca-1阳性骨髓HSC:通过流式细胞术分析和扫描电子显微镜的比较研究

获取原文
           

摘要

Self-renewing Hematopoietic Stem Cells (HSCs) are responsible for reconstitution of all blood cell lineages. Sca-1 is the “stem cell antigen” marker used to identify the primitive murine HSC population, the expression of which decreases upon differentiation to other mature cell types.Sca-1+HSCs maintain the bone marrow stem cell pool throughout the life. Aplastic anemia is a disease considered to involve primary stem cell deficiency and is characterized by severe pancytopenia and a decline in healthy blood cell generation system. Studies conducted in our laboratory revealed that the primitiveSca-1+BM-HSCs (bone marrow hematopoietic stem cell) are significantly affected in experimental Aplastic animals pretreated with chemotherapeutic drugs (Busulfan and Cyclophosphamide) and there is increased Caspase-3 activity with consecutive high Annexin-V positivity leading to premature apoptosis in the bone marrow hematopoietic stem cell population in Aplastic condition. TheSca-1bright, that is, “more primitive” BM-HSC population was more affected than the “less primitive” BM-HSCSca-1dim population. The decreased cell population and the receptor expression were directly associated with an empty and deranged marrow microenvironment, which is evident from scanning electron microscopy (SEM). The above experimental evidences hint toward the manipulation of receptor expression for the benefit of cytotherapy by primitive stem cell population in Aplastic anemia cases.
机译:自我更新的造血干细胞(HSC)负责所有血细胞谱系的重建。 Sca-1是用于鉴定原始小鼠HSC群体的“干细胞抗原”标记,在分化为其他成熟细胞类型后其表达会降低。Sca-1+ HSC终生维持骨髓干细胞池。再生障碍性贫血是一种被认为与原发性干细胞缺乏有关的疾病,其特征是严重的全血细胞减少症和健康血细胞生成系统的下降。在我们实验室进行的研究表明,原始的Sca-1 + BM-HSC(骨髓造血干细胞)在用化学治疗药物(Busulfan和Cyclophosphamide)预处理的再生障碍性动物中受到显着影响,并且Caspase-3活性增加,且膜联蛋白持续升高-V阳性导致再生障碍性骨髓中造血干细胞群体过早凋亡。 Sca-1bright,即“较原始的” BM-HSC群体比“较原始的” BM-HSCSca-1人口稀少。减少的细胞数量和受体表达与空的和混乱的骨髓微环境直接相关,这从扫描电子显微镜(SEM)可以明显看出。以上实验证据提示在再生障碍性贫血病例中通过原始干细胞群体操纵受体表达以利于细胞治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号